S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Piramal Pharma to Power Morpeth UK Facility with Solar Array

Piramal Pharma Solutions is moving to cut its carbon footprint by installing a 4.3 MWp solar power plant at its manufacturing site in Morpeth, UK. The project, slated for completion in early 2027, will leverage 6,200 solar panels to provide nearly a quarter of the facility's annual electricity demand.

Piramal Pharma to Power Morpeth UK Facility with Solar Array
Photo: Bio & News

The installation spans 16 acres and is expected to generate 3,950 MWh of renewable energy each year. Under a Power Purchase Agreement with solar developer Alight, the behind-the-meter setup will cover approximately 22% of the site’s power requirements. This shift is projected to offset 20,000 tonnes of carbon dioxide equivalent over the next 25 years.

Frank Bugg, Senior Vice President of UK & Europe Operations, stated that the initiative aligns with the company’s broader strategy to reduce Scope 1 and Scope 2 emissions by 42% by 2030. Rob Stait, Managing Director at Alight, noted that the collaboration serves as a practical model for industrial sites seeking to stabilize energy costs while simultaneously strengthening grid resilience.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!